Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus

Introduction: Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are the newest class of oral antihyperglycemic medications approved for the treatment of type 2 diabetes mellitus (DM2). Although they are not approved for use in type 1 diabetes mellitus (DM1), SGLT2 inhibitors may help DM1 patients a...

Descripción completa

Detalles Bibliográficos
Autores principales: El Hage, Lea, Kashyap, Sangeeta R, Rao, Pratibha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940598/
https://www.ncbi.nlm.nih.gov/pubmed/31894715
http://dx.doi.org/10.1177/2150132719895188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940598/
https://www.ncbi.nlm.nih.gov/pubmed/31894715
http://dx.doi.org/10.1177/2150132719895188

Ejemplares similares